ISG15 expression is significantly associated with different pathological stages in several cancers, including KIRC, PAAD (pancreatic adenocarcinoma), and SKCM (skin cutaneous melanoma), suggesting a potential role of ISG15 expression levels in dictating pathological progression. This evidence concerns the gene ISG15 and cancer.